Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.（BIO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
bio · 股价预测 · 14 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 14 位华尔街分析师
Buy
14 位分析师
共识
评级分布
12 个月目标价
High
$335
Consensus
$322
+9.4% upside
Low
$310
Median: $320 · Last Close: $293.92
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$321.67
9.4% upside
High Target
$335
14.0%
Low Target
$310
5.5%
Current Price
$293.92
as of today
Based on analyst price targets, the BIO stock price prediction for the next 12 months ranges from $310 to $335. The consensus BIO price forecast of $321.67 implies 9.4% upside from the current price of $293.92.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $305.68 | ↑ 4.00% |
1-day model range: $303.69–$307.67. Peak: $307.67 (+4.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $249 | -15.2% |
| 2028 | $227 | -22.9% |
| 2029 | $214 | -27.1% |
| 2030 | $207 | -29.5% |
| 2031 | — | -30.9% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BIO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-01 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2026-04-07 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2026-02-16 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-10-30 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-10-30 | Citigroup | Maintains | Buy→Buy |
| 2025-08-01 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-08-01 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-06-09 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-05-02 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-05-02 | UBS | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bio-Rad Laboratories, Inc. (BIO) stock. Of the recent 74 rating actions, 5 were upgrades and 4 were downgrades. 14 analysts currently cover BIO.
分析师推荐趋势
BIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2.6B
↓ 6.6% YoY
Revenue Next Year
$2.7B
↑ 3.3% YoY
EPS This Year
$9.04
EPS Next Year
$9.96
↑ 10.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast BIO EPS of $9.04 for the current fiscal year, based on estimates from 2 analysts. The BIO revenue forecast is $2.6B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
BIO 股价预测由两类独立数据源支撑：来自 14 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。BIO 的共识目标价为 $321.67（+9.4% 上行空间），分析师共识为 Buy。
BIO 的短期预测（明日）为 $305.68（+4.00%）。 BIO 对 2027 年的股价预测均值为 $249。 BIO 对 2030 年的预测区间为 $192–$222。
Bio-Rad Laboratories, Inc. 在 NYSE 上市，代码 BIO。BIO 在 2027 年的整体展望偏积极，在覆盖分析师中约 57% 对应 Buy 共识。
常见问题
BIO 预测 · 8 个问题根据 14 位华尔街分析师，BIO 的 12 个月平均目标价为 $321.67，最高 $335.00、最低 $310.00。若有图表，中位目标价可在上方查看。相对当前价 $293.92，隐含约 +9.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.